S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers

Hepatology

Volumn 56, Issue 3, 2012, Pages 982-993

  Tomasi, Maria Lauda ^a   Tomasi, Ivan ^b   Ramani, Komal ^a   Pascale, Rosa Maria ^c   Xu, Jun ^a   Giordano, Pasquale ^b   Mato, José M ^d   Lu, Shelly C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SASSARI   (Italy)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 1; MESSENGER RNA; METHIONINE ADENOSYLTRANSFERASE; PROTEIN UBC9; S ADENOSYLMETHIONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; COLON CANCER; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; IMMUNOPRECIPITATION; LIVER CANCER; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; SUMOYLATION; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; MICE; S-ADENOSYLMETHIONINE; SUMOYLATION; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84865570978     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25701     Document Type: Article

References (36)

1. Johnson ES. Protein modification by SUMO. Ann Rev Biochem 2004; 73: 355-382.
2. Muller S, Hoege C, Pyrowalakis G, Jentsch S. SUMO, ubiquitin's mysterious cousin. Nat Rev Mol Cell Biol 2001; 2: 202-210.
3. Johnson ES, Blogel G. Ubc9 is the conjugating enzyme for the ubiquitin-like protein Smt3p. J Biol Chem 1997; 272: 26799-26702.
4. Manza LL, Codreanu SG, Stamer SL, Smith DL, Wells KS, Roberts RL, et al. Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem Res Toxicol 2004; 17: 1706-1715.
5. Romanenko AM, Kinoshita A, Wanibuchi H, Wei M, Zaparin WK, Vinnichenko WI, et al. Involvement of ubiquitination and sumoylation in bladder lesions induced by persistent long-term low dose ionizing radiation in humans. J Urol 2006; 175: 739-743.
6. Wu F, Zhu S, Ding Y, Beck WT, Mo YY. MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clin Cancer Res 2009; 15: 1550-1557.
7. Moschos SJ, Smith AP, Mandic M, Athanassiou C, Watson-Hurst K, Jukic DM, et al. SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanoma. Oncogene 2007; 26: 4216-4225.
8. Moschos SJ, Jukic DM, Athanassiou C, Bhargava R, Dacic S, Wang X, et al. Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues. Hum Pathol 2010; 41: 1286-1298.
9. Tomasi ML, Iglesias-Ara A, Yang A, Ramani K, Feo F, Pascale MR, et al. S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis. Gastroenterology 2009; 136: 1025-1036.
10. Martínez-Chantar ML, Corrales FJ, Martínez-Cruz LA, Garcia-Trevijano ER, Huang ZZ, Chen L, et al. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J 2002; 16: 1292-1294.
11. Mato JM, Lu SC. Role of S-adenosyl-L-methionine in liver health and injury. HEPATOLOGY 2007; 45: 1306-1312.
12. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 1988; 15: 759-774.
13. Chen H, Xia M, Lin M, Yang H, Kuhlenkamp J, Li T, et al. Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology 2007; 133: 207-218.
14. Lu SC, Alvarez L, Huang ZZ, Chen L, An W, Corrales FJ, et al. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci USA 2001; 98: 5560-5565.
15. Ji C, Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 2003; 124: 1488-1499.
16. Yang H, Ara AI, Magilnick N, Xia M, Ramani K, Chen H, et al. Expression pattern, regulation, and functions of methionine adenosyltransferase 2beta splicing variants in hepatoma cells. Gastroenterology 2008; 134: 281-291.
17. Veal N, Hsieh CL, Xiong S, Mato JM, Lu SC, Tsukamoto H. Inhibition of lipopolysaccharide-stimulated TNF-alpha promoter activity by S-adenosylmethionine and 5′-methylthioadenosine. Am J Physiol Gastrointest Liver Physiol 2004; 287: G352-G362.
18. Ramani K, Yang H, Xia M, Iglesias-Ara A, Mato JM, Lu SC. Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2beta. HEPATOLOGY 2008; 4: 521-531.
19. Pascale RM, Simile MM, De Miglio MR, Muroni MR, Calvasi DF, Asara G, et al. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis. HEPATOLOGY 2002; 35: 1341-1350.
20. Mo YY, Yu Y, Theodosiou E, Ee PL, Beck WT. A role for Ubc9 in tumorigenesis. Oncogene 2005; 24: 2677-2683.
21. Lu Y, Wu D, Wang X, Ward SC, Cedarbaum AI. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. Free Radic Biol Med 2010; 15: 1406-1416.
22. Tomasi ML, Ramani K, Lopitz-Otsoa F, Rodriguez MS, Li TW, Ko K, et al. S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes. HEPATOLOGY 2010; 51: 2152-2161.
23. Yang H, Sadda MR, Li M, Zeng Y, Chen L, Bae W, et al. S-adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: role of protein phosphatase 1 and Bcl-xs. HEPATOLOGY 2004; 40: 221-231.
24. Wang SC, Nakajima Y, Yu YL, Chen CT, Yang CC, McIntush EW, et al. Tyrosine phosphorylation controls PCNA function through protein stability. Nature Cell Biology 2006; 8: 1359-1368.
25. Mahajan R, Gerace L, Melchior F. Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J Cell Biol 1998; 140: 259-270.
26. Chae SW, Sohn JH, Kim DH, Choi YJ, Park YL, Kim K, et al. Overexpressions of cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications. Yonsei Med J 2011; 52: 445-453.
27. Caraglia M, Giuberti G, Marra M, Addeo R, Montella L, Murolo M, et al. Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. Cell Death Dis 2011; 2: e150.
28. French SW. Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J Biomed Sci 2001; 8: 20-27.
29. Ara AI, Xia M, Ramani K, Mato JM, Lu SC. S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation. HEPATOLOGY 2008; 47: 1655-1666.
30. Westermarck J. Regulation of transcription factor function by targeted protein degradation: an overview focusing on p53, c-Myc, and c-Jun. Methods Mol Biol 2010; 64: 31-36.
31. Iakoucheva LM, Radivojac P, Brown CJ, O'Conner TR, Sikes JG, Obradovic Z, et al. The importance of intrinsic disorder for protein phosphorylation. Nucl Acids Res 2004; 32: 1037-1049.
32. Betting J, Seufert W. A yeast Ubc9 mutant protein with temperature-sensitive in vivo function is subject to conditional proteolysis by a ubiquitin-and proteasome-dependent pathway. J Biol Chem 1996; 271: 25790-25796.
33. Zhao XF, Gartenhaus RB. Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma. Expert Opin Ther Targets 2009; 13: 1085-1093.
34. Sarge KD, Park-Sarge OK. Sumoylation and human disease pathogenesis. Trends Biochem Sci 2009; 34: 200-205.
35. Lu SC, Ramani K, Ou X, Lin M, Yu V, Ko K, et al. S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model. HEPATOLOGY 2009; 50: 462-471.
36. Pascale RM, Simile MM, De Miglio MR, Nufris A, Daino L, Seddaiu MA, et al. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1, 2-dimethylhydrazine and promoted by orotic acid. Carcinogenesis 1995; 16: 427-430.